IQVIA™ (NYSE:IQV) today announced the launch of IQVIA Consumer Health, dedicated to supporting companies to drive innovation, operate more efficiently, optimize expanding product portfolios, and revitalize existing brands. IQVIA Consumer Health applies deep domain expertise, global and local regulatory intelligence, and insights that transform data into actionable strategies. This unique suite of solutions employs advanced technologies to help customers make quick, precise decisions to drive healthcare forward in a highly competitive market.
“IQVIA is committed to supporting the growing consumer health sector within the healthcare continuum,” said Prasanna Pitale, vice president and general manager, IQVIA Consumer Health. “IQVIA Consumer Health capabilities cover all aspects of the brand journey while also helping over-the-counter medicines, personal care, patient care and nutrition companies optimize their performance and ultimately give consumers better, healthier choices.”
IQVIA Consumer Health’s concept-to-consumer capabilities cover concept and strategy development, product and claim development, registration and market authorization, launch strategy and planning and commercialization and product lifecycle management.
For more information about IQVIA Consumer Health, visit http://iqviaconsumerhealth.comrhealth.com.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. With approximately 61,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.